Remicade for Inflammatory Bowel Disease User Reviews
- Leo...
- Taken for 1 to 6 months
- April 16, 2024
"I have had two loading doses of Remicade. I think it is working, but it is too early to tell. After the second dose, I felt ill for a week with symptoms of exhaustion, headache, poor appetite, and metallic taste in my mouth."
- Leo...
- Taken for less than 1 month
- March 29, 2024
"After my first infusion with Remicade, my IBS symptoms of diarrhea were lessened. But after my second infusion two weeks later, I experienced side effects that I had not experienced the first time. I felt exhausted, and my tinnitus was increased. My sense of taste and smell was diminished, and my appetite was poor."
Frequently asked questions
- What are the new drugs for rheumatoid arthritis (RA)?
- What are Monoclonal Antibodies and how do they work?
- Biosimilars vs Biologics: What are they and how do they compare?
- What is the difference between Inflectra and Remicade?
See also:
Reviews may be edited to correct grammar/spelling or remove inappropriate content. Reviews appearing to come from parties with a vested interest are not published. This information is not intended to endorse any medication and should not replace the expertise and judgment of healthcare professionals.
Learn more about Inflammatory Bowel Disease
Care guides
Medicine.com guides (external)
More about Remicade (infliximab)
- Check interactions
- Compare alternatives
- Pricing & coupons
- Reviews (214)
- Drug images
- Side effects
- Dosage information
- During pregnancy
- Support group
- FDA approval history
- Drug class: antirheumatics
- Breastfeeding
- En español
Patient resources
Other brands
Inflectra, Avsola, Renflexis, Zymfentra, Ixifi
Professional resources
Other brands
Inflectra, Avsola, Renflexis, Zymfentra
"My first infusion of Remicade, I pretty much slept through it. I have recurring eye infections that prohibit cataract surgery. My GI doctor, after consulting with other doctors in the field, thinks this is the best med for my issue. Time will tell."